baber/WOPTO huggingface dataset:
Patent AT-E222289-T1 (AT)
Inventor: HARTLEY JAMES L
IPC: C12N15/09
Filed: 1996-06-07
Granted: 2002-08-15
Abstract: Compositions and kits are provided for recombinational cloning. One composition comprises at least one isolated recombination protein and at least one isolated nucleic acid molecule comprising at least a first recombination site containing at least one mutation, wherein said mutation removes one or more stop codons from said recombination site. Another composition comprises at least one isolated recombination protein and at least one nucleic acid molecule comprising at least a first nucleic acid sequence selected from the group consisting of SEQ ID NOs:1-16, a complementary DNA sequence thereto, and an RNA sequence corresponding thereto. A further composition comprises at least one isolated recombination protein and at least one isolated nucleic acid molecule comprising at least a first recombination site containing at least one mutation, wherein said mutation avoids hairpin formation. Other compositions are as further defined in the claims.
Patent AT-E210168-T1 (AT)
Inventor: DUNKELMANN GUENTER DR
IPC: A24C5/56
Filed: 1997-01-08
Granted: 2001-12-15
Abstract: Iron oxide yellow pigments with silicon dioxide (SiO2) coating are claimed. Also claimed are special papers coloured with these pigments.
Patent AT-E194983-T1 (AT)
Inventor: HICKEY JOSEPH A
IPC: A01G7/00
Filed: 1993-05-19
Granted: 2000-08-15
Abstract: Solid mepiquat chloride sealed into a water-soluble pouch or into a water-soluble encapsulated solid form (e.g. granule, pellet, or briquette) for convenient handling. The pouch contains powdered mepiquat chloride or the encapsulated solid is merely introduced directly into a spray tank or reservoir for application with low human exposure and no containers in contact with the mepiquat chloride that require disposal. Mepiquat chloride can be used as a component of a system for growing a number of commodity plants including cotton.
Patent AT-E182598-T1 (AT)
Inventor: KRULL MATTHIAS DR
IPC: C10M159/12
Filed: 1997-05-10
Granted: 1999-08-15
Abstract: Terpolymers (I) of ethylene, 10-35 wt.% vinyl ester of a 2-20C aliphatic monocarboxylic acid and 0.5-20 wt.% norbornene (or norbornene derivative) have a 140 degrees C melt viscosity of 20-10,000 mPa.s. Also claimed are: (a) the preparation of (I) by radically-initiated polymerisation of a mixture of ethylene, 5-40 wt.% of the vinyl ester and 0.5-30 wt.% of the norbornene (or derivative) at 50-350 degrees C/50-400 MPa optionally with a moderator; and (b) (i) 20:1-1:20 mixtures of (I) with EVA copolymers or with ethylene/vinyl acetate/vinyl-neononanoate or -neodecanoate terpolymers or (ii) 1:10-20:1 mixtures of (I) with paraffin dispersants or with comb polymers; and (c) mineral oils or distillates containing 0.0005-1 wt.% of (I) or mixtures as in (b).
Patent AT-E217385-T1 (AT)
Inventor: HENKENJOHANN JOHANN
IPC: E06B9/80
Filed: 1997-07-21
Granted: 2002-05-15
Abstract: The device is fitted in an end bar (4) or in an end section of the door and works in conjunction with a drive, which on release it stays standstill or reversed for a short time. The door end bar or end section, has a locking insert (10) with a vertically movable locking strip (11). At least one switch (14) is provided to the insert and its input and output is transferred via connecting lines (14.1,14.2).   The switch inputs and outputs may be connected via contact strips provided in the lateral guide profiles (6) with the drive control as a monitoring circuit. Two switches may be provided, connected in series, each near the side ends of the lower end profile or the end section.
Patent AT-E453377-T1 (AT)
Inventor: GERS-BARLAG HEINRICH
IPC: A61K8/29
Filed: 1997-10-25
Granted: 2010-01-15
Abstract: Use of at least one inorganic hydrophobic pigment is claimed to achieve or improve the water-resistance of a light protection cosmetic or dermatological formulation in the form of an O/W or W/O emulsion which is free from polyethoxylated emulsifier. The pigment is in the oil phase; and the formulation contains (c) at least one UV filter containing a sulphonic acid or sulphonate group; (d) at least one surface active agent of formula (Ia); and (e) at least one surface active agent of formula (Ib). R = 1-24C alkyl; R1, R2 = H or 1-24C alkyl; R3-R5 = H, or 8-24C saturated or unsaturated fatty acid optionally mono- to tri-substituted by OH; and n = 0-8.
Patent AT-E201893-T1 (AT)
Inventor: LUEDDECKE ERIK DR
IPC: A61K8/92
Filed: 1997-11-03
Granted: 2001-06-15
Abstract: A liquid, oil-miscible carotenoid (I) preparation (A) comprises a double dispersion system, consisting of a dispersion in oil of droplets (having particle size below 100 mu m) of an aqueous phase containing dispersed particles of (I) stabilised by a protective colloid.
Patent AT-E242545-T1 (AT)
Inventor: VANDEN BRANDE PIERRE
IPC: C23C14/22
Filed: 1997-10-08
Granted: 2003-06-15
Abstract: A device for forming a coating on a substrate (8) by condensation of an element, notably a metal, incorporates a conducting wall (9, 9a, 9b) delimiting at least laterally the space (2') between the target (7) and the substrate (8) with provision for negative or positive polarization of this wall (9, 9a, 9b) with respect to the substrate (8). The device comprises:- a) an enclosure (2) in which is a target (7) presenting at least a surface layer of the material to be condensed onto the substrate; b) some means (1) for evaporating this material; and/or c) some means for producing the cathodic pulverization of this material from the target (7) to the substrate (8).
Patent AT-E232246-T1 (AT)
Inventor: KINOSHITA NAOYUKI
IPC: A41B11/00
Filed: 1997-03-27
Granted: 2003-02-15
Abstract: A highly hygroscopic polyamide fiber formed from a polyamide composition containing a polyvinylpyrrolidone (in an amount of 3-15 wt%), which may be synthesized in isopropyl alcohol as a solvent, in which any pyrrolidone which may be present is present in an amount less than 0.1 wt%, and which polyvinylpyrrolidone has a K-value of 20-70. This fiber is characterised by a yellowness index lower than 10 before dying, a large difference between the maximum moisture absorptivity and the standard moisture absorptivity, and a low content of water-soluble components that are subject to leaching.
Patent AT-E204038-T1 (AT)
Inventor: STRAHM CHRISTIAN
IPC: D06C29/00
Filed: 1997-04-18
Granted: 2001-08-15
Abstract: Fibrillating a web of textile fabric (3) containing cellulose fibres, particularly Lyocell (RTM) fibres, comprises using a high-velocity stream of fluid impinging on the spread-out web and accelerating it to strike against an impact surface (13, 16). This procedure is repeated as often as needed till the fibre surface regions split and form fibrils. Also claimed is the apparatus for implementing the process of fibrillating web as above, in particular Tencel (RTM) fibres. The web is accelerated by the flowing fluid in a guiding gap (7) which is bounded on at least one side by a jet (9a, 9b, 10a, 10b) which has a fluid feed channel (12) and, on two opposite sides, a nozzle-like gap exit (10a, 10b) which narrows towards the guide gap. There is a valve (11) which closes each of the exits alternately.
Patent AT-E381314-T1 (AT)
Inventor: LEE DOSUK
IPC: A61K9/00
Filed: 1997-10-16
Granted: 2008-01-15
Abstract: The present invention provides a synthetic, poorly crystalline apatite (PCA) calcium phosphate containing a biologically active agent and/or cells (preferably tissue-forming or tissue-degrading cells). The compositions provided by the present invention are useful for a variety of in vivo and in vitro applications, including drug delivery (for example, to bony sites, the central nervous system, intramuscular sites, subcutaneous sites, interperitoneal sites, and occular sites) tissue growth (preferably bone or cartilage) osseous augmentation, and methods of diagnosing disease states by assaying tissue forming potential of cells isolated from a host. The invention also provides methods of preparing delivery vehicles, of altering delivery vehicle characteristics, and of delivering biologically active agents to a site. The invention further provides in vitro cell culture systems and cell encapsulation materials. The invention is useful for both medical and veterinary applications.
Patent AT-E216441-T1 (AT)
Inventor: AMBERG GUENTHER
IPC: D06F39/02
Filed: 1997-10-17
Granted: 2002-05-15
Abstract: The invention relates to an assembly for delivering a paste from a flexible supply packing drum (6) to a dosing device (2). Said packing drum is arranged in a dimensionally stable container (4) and has descending product guidance. The dosing device delivers by means of a low pressure. In addition, a follower plate (7) is arranged on the flexible supply packing drum (6). Said follower plate exerts pressure on the supply packing drum (6). An opening (9) is provided in the bottom of the container (4). The container (4) is sealed against the dosing device (2) and the follower plate (7) is sealed against and moveable within the container (4). A low pressure is applied between the container (4, 5) and the flexible supply packing drum (6).
Patent AT-E261656-T1 (AT)
Inventor: NOWAK MILTON
IPC: A01N25/04
Filed: 1997-10-29
Granted: 2004-04-15
Abstract: A water miscible composition consisting essentially of a solvating surfactant selected from the group consisting of an alkoxylated castor oil, an alkoxylated hydrogenated castor oil and an alkoxylated rosin, and a biocidal biologically active material dissolved in said solvating surfactant useful to prepare aqueous microemulsions, micellar solutions or molecular solutions of said biocidal biologically active material upon mixing with water.
Patent AT-E325154-T1 (AT)
Inventor: MATTHEWS BARRY ROSS
IPC: A61K31/74
Filed: 1997-07-17
Granted: 2006-06-15
Abstract: For proposes of prophylactic or treatment of diseases related to inappropriate angiogenesis, a compound can be administered that is (i) a linear, non-carbohydrate polymer having a plurality of side chain groups or (ii) a dendrimer having a plurality of terminal groups. At least one of the side chain groups of the linear, non-carbohydrate polymer has an anionic- or cationic-containing moiety bonded or linked thereto. The plurality of terminal groups of the dendrimer has at least one anionic- or cationic-containing moiety bonded or linked thereto.
Patent AT-E278749-T1 (AT)
Inventor: XIAO ZHIGUO
IPC: C09K11/59
Filed: 1997-12-12
Granted: 2004-10-15
Abstract: Disclosed is a long afterglow silicate luminescent materials which have a main chemical composition formula of: aMO.bM'O.cSiO2.dR: Eux,Lny, wherein M represents one or more elements selected from a group consisting of Sr, Ca, Ba and Zn; M' represents one or more elements selected from a group consisting of Mg, Cd and Be; R represents one or two components selected from B2O3 and P2O5;Ln represents one or more elements selected from a group consisting of Nd, Dy, Ho, Tm, La, Pr, Tb, Ce, Mn, Bi, Sn and Sb; a, b, c, d, x and y are mole coefficients; wherein: 0.6≤a≤6, 0≤b≤5, 1≤c≤9, 0≤d≤0.7, 0.00001≤x≤0.2, and 0≤y≤0.3; these luminescent materials have long afterglow characteristic after absorbing short wavelength lights. <IMAGE>
Patent AT-E207071-T1 (AT)
Inventor: MEYER MICHAEL D
IPC: A61K31/517
Filed: 1997-12-04
Granted: 2001-11-15
Abstract: The present invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are  alpha -1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are  alpha -1 antagonist compositions and a method for antagonizing  alpha -1 adrenoreceptors and treating BPH.
Patent AT-E199379-T1 (AT)
Inventor: KARSTENS TIES
IPC: C08B37/14
Filed: 1997-12-22
Granted: 2001-03-15
Abstract: A method for processing guar endosperm in which guar splits are brought into contact with an amount of liquid ammonia at least sufficient to wet the guar splits at a pressure higher than atmospheric pressure and at a temperature of at least 25° C. The remaining available guar split/liquid ammonia system volume is increased in an explosion like manner by reducing the pressure by at least about 5 bars resulting in the sheaths of the guar splits being torn open to result in a product that can be processed more easily, such as by grinding.
Patent AT-E222690-T1 (AT)
Inventor: HOHLBAUM BERND DR ING
IPC: A01G31/00
Filed: 1998-11-06
Granted: 2002-09-15
Abstract: A plant substrate (I), made of predominantly fibers that are longer than 15mm and thinner than 7, preferably 3dtex, especially made of waxy raw materials, is new. A plant substrate (I), made of predominantly fibres that are longer than 15mm and thinner than 7, preferably 3dtex, especially made of waxy raw materials, is new. (I) is enclosed in an area of between 10 - 100kg per m<3>, so that the fibers are built in a vertical orientation with a constant thickness. The height of (I) and the presence of air holes with a radius of no more than 200 mu m forms a distinctive vertical capillary movement. (I) is fixed through thermal solidification with natural organic binding materials such as proteins, tannins, lignins and carbohydrates, or with binding fibers and/or other thermo- or duroplastic or soluble binding systems, or a mixture of these. (I) has a moisture storage capacity of at least 40 volume % and a minimum air storage capacity of at least 10 volume %, without additional moisture absorption from the total capillary storage and from the spaces and substances of the single fibers.
Patent AT-E260104-T1 (AT)
Inventor: ZUCKERMAN STEVEN HAROLD
IPC: C07D333/56
Filed: 1994-12-19
Granted: 2004-03-15
Abstract: The use of a compound having the formula <CHEM>  wherein R<1> and R<3> are independently hydrogen, <CHEM>  or <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected-from the group consisting of pyrrolidino and piperidino; or a pharmaceutically acceptable salt or solvate thereof, in the preparation of a medicament useful for inhibiting LDL oxidation.
Patent AT-E244228-T1 (AT)
Inventor: MATSUNAGA TOMONORI
IPC: C07D277/20
Filed: 1998-02-13
Granted: 2003-07-15
Abstract: The present invention relates to a simple process for producing 2-aminothiazoleacetic acid derivatives useful as intermediates for producing cephalosporin-type antibiotics. The process for producing chloroacetylaminothiazoleacetic acid derivatives represented by the following formula (II) <CHEM>     wherein R1 is a protection group for the hydroxyl group, comprises reacting aminothiazoleacetic acid derivatives represented by the following formula (I) <CHEM>     wherein R1 is a protection group for the hydroxyl group, with a chloroacetylating agent.
Patent AT-E307119-T1 (AT)
Inventor: DOBRUSIN ELLEN M
IPC: A61K31/4164
Filed: 1998-02-11
Granted: 2005-11-15
Abstract: PCT No. PCT/US98/03025 Sec. 371 Date Aug. 2, 1999 Sec. 102(e) Date Aug. 2, 1999 PCT Filed Feb. 11, 1998 PCT Pub. No. WO98/34921 PCT Pub. Date Aug. 13, 1998The present invention provides compounds of Formula (I). The present invention also provides a method of treating cancer and treating or preventing restenosis or atherosclerosis. Also provided by the present invention is a pharmaceutically acceptable composition containing a compound of Formula (I).
Patent AT-E301624-T1 (AT)
Inventor: BINGEL CARSTEN
IPC: C07D333/16
Filed: 1998-03-05
Granted: 2005-08-15
Abstract: A process for the preparation of indanones of the formula II from indanones of the formula I or of indanones of the formula IIa from indanones of the formula Ia comprises reacting an indanone of the formula I or Ia with a coupling component.
Patent AT-E278397-T1 (AT)
Inventor: KUNZ LAWRENCE L
IPC: A61P9/00
Filed: 1998-03-31
Granted: 2004-10-15
Abstract: Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a method to inhibit or reduce vascular remodeling following vascular trauma, comprising administering an effective amount of a cytoskeletal inhibitor. Further provided are pharmaceutical compositions and kits comprising the therapeutic agents of the invention.
Patent AT-E211264-T1 (AT)
Inventor: LEVECQ XAVIER
IPC: G01B11/00
Filed: 1998-03-20
Granted: 2002-01-15
Abstract: The invention concerns an optical device for the contactless measurement of the distance of a light source (4) comprising optical detecting means (7) consisting of elementary sensors and further comprising: a set of N imaging means (SP1, SP2, SP3), N>=3, that enable image acquisition of the light source on a plane in the proximity of the detecting means thereby forming with said means a set of hot spots, each spot spreading over at least two elementary sensors; a circuit for computing, on the basis of the relative positions of at least three hot spots, at least one characteristic parameter of the distance from the light source whereof the accuracy depends on N number of hot spots. The measuring device is characterized in that it is designed for industrial measurements (of dimensions, texture, position, vibrations, displacement).
Patent AT-E243502-T1 (AT)
Inventor: CREMASCHI DARIO
IPC: A61K9/50
Filed: 1998-04-08
Granted: 2003-07-15
Abstract: Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration.
Patent AT-E282625-T1 (AT)
Inventor: JOHNSTON GRAHAM A R
IPC: A61K31/675
Filed: 1998-06-23
Granted: 2004-12-15
Abstract: The invention provides methods for enhancing cognitive activity and stimulating memory capacity, comprising the step of administering an effective amount of a compound with GABA<HIL><PDAT>C </SB><PDAT>receptor antagonist activity to an animal in need of such treatment. Preferably the compound has selective GABA<HIL><PDAT>c </SB><PDAT>receptor antagonist activity, and more preferably comprises a phosphinic acid group. The invention also provides novel compounds and compositions. The methods of the invention are useful in the treatment of dementias and conditions involving cognitive deficit, or memory impairment.</PTEXT>
Patent AT-E311496-T1 (AT)
Inventor: JACKSON ANDREW CLIVE
IPC: C07C323/12
Filed: 1998-09-02
Granted: 2005-12-15
Abstract: A paper production process, characterized by the process step of providing to the paper at some point in the production process a compound of formula (I)which reduces the tendency of the obtained paper products, particularly those made from high-yield pulps, to yellow on exposure to light.
Patent AT-E212811-T1 (AT)
Inventor: DENNIS SIMON
IPC: A47B57/04
Filed: 1998-09-15
Granted: 2002-02-15
Abstract: A connection unit 2 enables a transverse beam 4 to be connected to a horizontal beam 6. The horizontal beam 6 defines a guide channel 8 which is engaged by the connection unit 2 and along which the unit 2 can be slid to a desired position. The roof and floor of the beam 6 are provided with spaced pairs of aligned openings 10 and 12. The connection unit 2 has a series of vertically spaced horizontally extending lands 16 for supporting the horizontal beam 6 at different vertical levels. A pair of openings 20 and 22 having the same spacing as the openings 10 and 12 extend through the connection unit 2 to pass through both the recess 14 and all the lands 16 therein. A pair of locking pins 24 and 26 are provided to lock the three components together.
Patent AT-E200953-T1 (AT)
Inventor: SCHIMITZEK PETER
IPC: A22B5/00
Filed: 1998-07-04
Granted: 2001-05-15
Abstract: The invention relates to a method for evaluating half-carcasses by means of optical image processing which is acquired at the arrival of articles, at classification points or at the departure of articles of meat-packing and meat processing. According to said method, a single color image (1) of half-carcass parts taken by an optical sensor is automatically evaluated by means of electronic data processing. The aim of the method is to develop an automatic evaluation method for half-carcasses which is carried out using contactless measuring methods based on standardized methods of evaluation. Said evaluation method allows for quick, objective and transparent determination of commercial grade and, optionally, commercial value as well as enabling each measurement to be uniformly carried out in slaughter and meat processing. This is accomplished by a reliable evaluation of carcasses according to the definition of commercial grade that occurs through the evaluation of commercial grade and/or determination of commercial value by means of optical image evaluation accessible to parameters located outside the loin region according to the ZP-Method, such that the method of evaluation through analysis of other body regions, including a certain amount of latitude, will not be necessarily complicated and expensive in practice. Following preliminary steps within image analysis corresponding to the assigned contour lines, the half-carcass is classified according to the ZP-Method. Said ZP-Method contains two points. At the first point of the ZP-Method (15), the minimal bacon thickness (14) is calculated. At a second point of the ZP-Method (17), said point being the point of intersection (16) between the bacon/middle rump muscle (11) and the middle rump muscle/fat border (12), the muscle thickness (18) is calculated up to the bone marrow canal (13).
Patent AT-E292796-T1 (AT)
Inventor: KOUZNETSOV ANDRIAN
IPC: G01N21/35
Filed: 1998-10-21
Granted: 2005-04-15
Abstract: A diffusion-type NDIR gas analyzer with an improved response time due to convection flow created by a temperature gradient between gas located within a waveguide and gas located within a diffusion pocket of space created between the waveguide and a semi-permeable membrane which surrounds the waveguide. The temperature gradient may be created by a thermally resistive radiation source that is not thermally isolated from the waveguide. The semi-permeable membrane is made of a hydrophobic material and has a thickness sufficient to provide its own structural integrity. The semi-permeable membrane can have a porosity less than approximately 50 microns and be comprised of ultra high molecular weight polyethylene or Teflon(R).
Patent AT-E302769-T1 (AT)
Inventor: KOEHLER GUENTHER DR
IPC: C07B61/00
Filed: 1999-01-29
Granted: 2005-09-15
Abstract: Preparation of macrocyclic esters comprises cyclising a dicarboxylic acid bis(glycol) ester by heating (a) the bis(glycol) ester, (b) a similar ester, (c) an alkylene glycol, (d) an inert, high-boiling reaction medium and (e) a catalyst, to 150-350 degrees C/0.1-500 mbar such that glycol is split-off and the macrocyclic ester is distilled-off and separated from glycol (c) by condensation. Preparation of macrocyclic esters of formula (I) comprises cyclising a dicarboxylic acid bis(glycol) ester of formula (II) by heating a mixture comprising (a) the bis(glycol) ester (II), (b) optionally up to 100% (based on wt. of (a)) of a similar ester of formula (III) - (V), (c) an alkylene glycol of formula (VI) in an amount of 1-50 mols. per mol. of (a) + (b), (d) an inert, high-boiling reaction medium in an amount of 1-20 parts wt. per part wt. of (a) + (b) and (e) a catalyst, the reaction being in a large-surface evaporator to 150-350 degrees C at 0.1-500 mbar such that glycol is split-off, with the macrocyclic ester being distilled-off and separated from glycol (c) by condensation. HO(CH2)nOCO(CH2)mCOO(CH2)nOH (II) H(O(CH2)nOCO(CH2)mCO)xO(CH2)nOH (III) H(O(CH2)nOCO(CH2)mCO)xOH (IV) HOCO(CH2)mCO(O(CH2)nOCO(CH2)mCO)xOH (V) HO(CH2)nOH (VI) m = 6-14; n = 2-6; and x = integer above 1.